Supplementary Table S5 from Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma
收藏数据链接：
官方服务：
资源简介：
Summary statistics for nucleosome footprints at YES1 and IGF1R regulatory motifs
针对YES1与IGF1R调控基序（regulatory motifs）处核小体足迹（nucleosome footprints）的汇总统计
创建时间：
2023-07-18
